Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas W Geisbert

Showing results (151-160 of 279) with videos related to

Pageof 28
Sort By:
The Journal of Infectious Diseases|June 26, 2018
Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman PrimatesCourtney Woolsey, Joan B Geisbert, Demetrius Matassov, et al.
Nature Communications|April 23, 2025
Remdesivir, mAb114, REGN-EB3, and ZMapp partially rescue nonhuman primates infected with a low passage Kikwit variant of Ebola virusAbhishek N Prasad, Courtney Woolsey, Viktoriya Borisevich, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2022
A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus diseaseStephanie L Foster, Courtney Woolsey, Viktoriya Borisevich, et al.
Plos One|May 27, 2010
Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infectionThomas W Geisbert, Kathleen M Daddario-DiCaprio, Andrew C Hickey, et al.
The Journal of Infectious Diseases|October 12, 2011
Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirusDarryl Falzarano, Friederike Feldmann, Allen Grolla, et al.
Plos Pathogens|January 24, 2007
Effective post-exposure treatment of Ebola infectionHeinz Feldmann, Steven M Jones, Kathleen M Daddario-DiCaprio, et al.
Genome Biology|August 30, 2007
The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic feverKathleen H Rubins, Lisa E Hensley, Victoria Wahl-Jensen, et al.
Emerging Microbes & Infections|June 3, 2022
Natural history of <i>Sudan ebolavirus</i> infection in rhesus and cynomolgus macaquesCourtney Woolsey, Alyssa C Fears, Viktoriya Borisevich, et al.
Cell Reports|February 16, 2016
Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 ProteinsMegan R Edwards, Gai Liu, Chad E Mire, et al.
Scientific Reports|August 4, 2016
Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody TherapyChad E Mire, Benjamin A Satterfield, Joan B Geisbert, et al.
Pageof 28

Showing results (151-160 of 279) with videos related to

Sort By:
Pageof 28
The Journal of Infectious Diseases|June 26, 2018
Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman PrimatesCourtney Woolsey, Joan B Geisbert, Demetrius Matassov, et al.
Nature Communications|April 23, 2025
Remdesivir, mAb114, REGN-EB3, and ZMapp partially rescue nonhuman primates infected with a low passage Kikwit variant of Ebola virusAbhishek N Prasad, Courtney Woolsey, Viktoriya Borisevich, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2022
A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus diseaseStephanie L Foster, Courtney Woolsey, Viktoriya Borisevich, et al.
Plos One|May 27, 2010
Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infectionThomas W Geisbert, Kathleen M Daddario-DiCaprio, Andrew C Hickey, et al.
The Journal of Infectious Diseases|October 12, 2011
Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirusDarryl Falzarano, Friederike Feldmann, Allen Grolla, et al.
Plos Pathogens|January 24, 2007
Effective post-exposure treatment of Ebola infectionHeinz Feldmann, Steven M Jones, Kathleen M Daddario-DiCaprio, et al.
Genome Biology|August 30, 2007
The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic feverKathleen H Rubins, Lisa E Hensley, Victoria Wahl-Jensen, et al.
Emerging Microbes & Infections|June 3, 2022
Natural history of <i>Sudan ebolavirus</i> infection in rhesus and cynomolgus macaquesCourtney Woolsey, Alyssa C Fears, Viktoriya Borisevich, et al.
Cell Reports|February 16, 2016
Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 ProteinsMegan R Edwards, Gai Liu, Chad E Mire, et al.
Scientific Reports|August 4, 2016
Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody TherapyChad E Mire, Benjamin A Satterfield, Joan B Geisbert, et al.
Pageof 28